Recombinant immunotoxins in the treatment of cancer

Methods Mol Biol. 2004:248:503-18. doi: 10.1385/1-59259-666-5:503.

Authors

Ira Pastan¹, Richard Beers, Tapan K Bera

Affiliation

¹ Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

PMID: 14970517
DOI: 10.1385/1-59259-666-5:503

No abstract available

MeSH terms

Animals
Base Sequence
Cell Line, Tumor
DNA Primers
DNA, Complementary
Immunotoxins / therapeutic use*
Neoplasms / drug therapy*
Recombinant Proteins / therapeutic use

Substances

DNA Primers
DNA, Complementary
Immunotoxins
Recombinant Proteins